Art. 5 Directive (EU) 1998/44

In forcesince 6 Jul 1998cited 10×
1.

The human body, at the various stages of its formation and development, and the simple discovery of one of its elements, including the sequence or partial sequence of a gene, cannot constitute patentable inventions.

2.

An element isolated from the human body or otherwise produced by means of a technical process, including the sequence or partial sequence of a gene, may constitute a patentable invention, even if the structure of that element is identical to that of a natural element.

3.

The industrial application of a sequence or a partial sequence of a gene must be disclosed in the patent application.

  • Judgment of the Court of 9 October 2001. Kingdom of the Netherlands v European Parliament and Council of the European Union.Decision

    As regards respect for human dignity, this is guaranteed in principle by Article 5(1) of the Directive which provides that the human body at the various stages of its formation and development cannot constitute a patentable invention.

    9 Oct 2001 · 61998CJ0377

  • Judgment of the Court (Third Chamber) of 16 June 2005. Commission of the European Communities v Italian Republic.Decisionrelated

    … Declares that, by having failed to adopt the laws, regulations and administrative provisions necessary to comply with Articles 3(1), 5(2), 6 (2) and 8 to 12 of Directive 98/44/EC of the European Parliament and of the Council of 6 July 1998 …

    16 Jun 2005 · 62003CJ0456

  • Judgment of the Court (Grand Chamber) of 18 October 2011. Oliver Brüstle v Greenpeace eV.Decision

    To that effect, as the Court has already held, Article 5(1) of the Directive provides that the human body at the various stages of its formation and development cannot constitute a patentable invention. Additional security is offered by …

    18 Oct 2011 · 62010CJ0034

  • Opinion of Mr Advocate General Jacobs delivered on 14 June 2001. Kingdom of the Netherlands v European Parliament and Council of the EuropeaDecision

    The Directive requires Member States to protect biotechnological inventions under national patent law. [Article 1(1).] Although there is no definition of ‘biotechnological inventions’, it is clear that the concept essentially comprises …

    14 Jun 2001 · 61998CC0377

  • Opinion of Mr Advocate General Bot delivered on 10 March 2011. Oliver Brüstle v Greenpeace eV.Decision

    In my view, embryonic stem cells must be regarded as elements isolated from the human body within the meaning of Article 5(2) of Directive 98/44. As Mr Brüstle explains in his observations to the Court, embryonic stem cells are obtained …

    10 Mar 2011 · 62010CC0034

  • Opinion of Advocate General Cruz Villalón delivered on 17 July 2014. International Stem Cell Corporation v Comptroller General of Patents, DDecision

    Article 5(1) and (2) of the Directive provides: ‘1. The human body, at the various stages of its formation and development, and the simple discovery of one of its elements, including the sequence or partial sequence of a gene, cannot …

    17 Jul 2014 · 62013CC0364

  • Judgment of the Court (Grand Chamber) of 6 July 2010. Monsanto Technology LLC v Cefetra BV and Others.Decision

    Moreover, the import of recitals 22 and 24 in the preamble to, and Article 5(3) of the Directive is that a DNA sequence does not enjoy any protection under patent law when the function performed by that sequence is not specified.

    6 Jul 2010 · 62008CJ0428

  • Judgment of the Court (Grand Chamber), 18 December 2014. International Stem Cell Corporation v Comptroller General of Patents, Designs and TDecision

    Article 5(1) and (2) of that directive provides: ‘1. The human body, at the various stages of its formation and development, and the simple discovery of one of its elements, including the sequence or partial sequence of a gene, cannot …

    18 Dec 2014 · 62013CJ0364

  • Opinion of Mr Advocate General Mengozzi delivered on 9 March 2010. Monsanto Technology LLC v Cefetra BV and Others.Decision

    In the first place, various provisions of Directive 98/44 highlight the fact that, in order to be able to obtain a patent relating to a DNA sequence, it is necessary to specify the function performed by that sequence. I would refer in that …

    9 Mar 2010 · 62008CC0428

  • Opinion of Mr Advocate General Ruiz-Jarabo Colomer delivered on 10 March 2005. Commission of the European Communities v Italian Republic.Decision

    Second, the Commission complains that Article 5(2) of the Directive, which permits the patenting of an element isolated from the human body, has not been implemented in Italian law.

    10 Mar 2005 · 62003CC0456